Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
People
Merck Wins Vioxx Case
Drugmaker has now won one case and lost another
by Michael McCoy
November 3, 2005
Merck & Co. won a victory in its battle over the painkiller Vioxx when a New Jersey state court jury returned a verdict rejecting the claims of an Idaho man who suffered a heart attack after taking Vioxx. The case is the second involving the drug to go to court. In the first case, in Texas, a jury awarded the widow of a Vioxx patient $253 million in damages. Merck general counsel Kenneth C. Frazier said that “there will be other Vioxx trials, and we will vigorously defend them one by one over the coming years.”
You might also like...
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X